Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3370320 | 0.92 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3373268 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL37597 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL7110706 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3369909 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL10589508 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL37783 | 0.90 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL19679395 | 0.88 | EPHX1 (0.34) | EPHX1TSHRTDP1 | |
| SCHEMBL27577156 | 0.88 | EPHX1 (0.39) | EPHX1TSHRALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL8041489 | 0.87 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865163-B2 | Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds | THE UNIVERSITY OF TOLEDO (US) | 2020-12-15 | — | — | US | claimed |
| US-20190185392-A1 | Carbon Dioxide as a Directing Group for C-H Functionalization Reactions Involving Lewis Basic Amines, Alcohols, Thiols, and Phosphines for the Synthesis of Compounds | THE UNIVERSITY OF TOLEDO (US) | 2019-06-20 | — | — | US | claimed |
| CN-116769408-A | Pressure-sensitive adhesive sheet | 日东电工（上海松江）有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116769409-A | Pressure-sensitive adhesive sheet | 日东电工（上海松江）有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-113382859-B | Surface protective film | 日东电工株式会社 | 2023-08-11 | — | — | CN | disclosed |
| CN-116034147-A | Adhesive composition containing antistatic agent and surface protective film | 株式会社LG化学 | 2023-04-28 | — | — | CN | disclosed |
| CN-115097551-A | Optical member with surface protective film | 日东电工株式会社 | 2022-09-23 | — | — | CN | disclosed |
| CN-114907787-A | Adhesive sheet and optical member | 日东电工株式会社 | 2022-08-16 | — | — | CN | disclosed |
| CN-114716944-A | Surface protective film | 日东电工株式会社 | 2022-07-08 | — | — | CN | disclosed |
| CN-114605931-A | Surface protective film | 日东电工株式会社 | 2022-06-10 | — | — | CN | disclosed |
| CN-110476003-B | Heat insulation base plate | 日东电工株式会社 | 2022-04-22 | — | — | CN | disclosed |
| CN-1667071-A | Adhesive composition, adhesive sheets and surface protective film | NITTO DENKO CORP (JP) | 2005-09-14 | — | — | CN | disclosed |
| EP-0994108-B1 | PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-05-14 | — | — | EP | disclosed |
| CN-1084739-C | Process for producing 2-hydroxybenzamide derivatives | ZERIA PHARMACEUTICAL CO.,LTD. (JP) | 2002-05-15 | — | — | CN | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-6197970-B1 | REACTING WITH SECONDARY OR TERTIARY AMINE; DEBLOCKING, DEPROTECTING | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| CN-1261357-A | Process for preparing 2-hydroxybenzamide derivatives | ZERIA PHARM CO LTD (JP) | 2000-07-26 | — | — | CN | disclosed |
| EP-0994108-A1 | PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-19 | — | — | EP | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185392-A1 | Carbon Dioxide as a Directing Group for C-H Functionalization Reactions Involving Lewis Basic Amines, Alcohols, Thiols, and Phosphines for the Synthesis of Compounds | CHKB, HRH3, PNMT | EPHX1 1492/4885TSHR 1440/4885ALDH1A1 1501/4885 |
| US-10865163-B2 | Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds | CHKB, HRH3, PNMT | EPHX1 1556/4885TSHR 1464/4885ALDH1A1 1388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.